stockportfolio.pro
Stocks / CBT vs CSTM
CBT vs CSTM
Cabot Corporation and Constellium SE side by side — fundamentals from SEC filings, refreshed nightly. Sector: Basic Materials.
| Cabot Corporation (CBT) | Constellium SE (CSTM) | |
|---|---|---|
| Market cap | $4.3B | $4.6B |
| Revenue (latest FY) | $3.71B | $8.45B |
| Net income (latest FY) | $331.00M | $273.00M |
| Revenue growth (5y CAGR) | 7.3% | -0.3% |
| Net margin | 8.9% | 3.2% |
| Return on equity | 21.4% | 28.7% |
| P/E ratio | 15.8 | 10.8 |
| Dividend yield | 2.2% | — |
| Profitable years (of last 10) | 8 | 4 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CBT — free Open CSTM — freeFrequently asked questions
Which is bigger, CBT or CSTM?
Constellium SE is larger by market capitalization — $4.6B versus $4.3B.
Which grows faster, CBT or CSTM?
Over the last five fiscal years, Cabot Corporation grew revenue faster — 7.3%/yr versus -0.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.